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Part VIII

Conclusions, Recommendations, Priorities

In this ﬁnal chapter, we summarize important
policy implications of the commission reports
and highlight steps they suggest to advance the
healthy development of America’s youth. The reports provide a hopeful assessment of our ability
to treat the most prevalent adolescent disorders.
At the same time, enormous hurdles remain in
our ability to deliver these treatments, and our
knowledge base of effective treatments still has
important gaps. These considerations suggest
that we face formidable challenges if we wish to
ensure the healthy development of our youth.
Nevertheless, our ever-growing understanding of
environments that encourage healthy development bodes well for our future ability to both
treat and prevent adolescent mental disorder.
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TREATMENT WORKS
The good news in the commission reports is that
the most common disorders (anxiety and depression) have effective treatments that can help
more than 70% of those who are afﬂicted. Those
who do not respond to particular treatments
can be given alternative therapies that can raise
the success rate even higher. Although combination treatments involving both drugs and
psychotherapy are often most effective, it is also
the case that psychotherapy, in particular
cognitive-behavior (CBT) or interpersonal (IPT)
approaches, can reduce symptoms and lead to
improvement without the use of medication.
There is also progress in the treatment of the
less prevalent conditions. Treatments for bipolar
disorder have a high success rate, and therapeutic interventions for anorexia nervosa can lead
to recovery from this illness. Early intervention
can also beneﬁt those with schizophrenia, reducing the severity of the illness and leading to
better adaptation to the disorder. Since many
with severe mental disorders are at risk for suicide, these interventions can be not only life altering but also life saving.
As discussed below, the ﬁndings also have important implications for the reduction of stigma
associated with mental illness. Public awareness
of the effectiveness of treatment for mental disorders should increase the willingness of parents
and youth to seek treatment before illness pro-

gresses. Stigma reduction throughout society
should also increase the likelihood that those
who have been successfully treated will lead productive and satisfying lives.

RECENT DEVELOPMENTS IN THE USE OF
MEDICATION TO TREAT ADOLESCENT
DEPRESSION
As this book goes to press, there is vigorous discussion about the safety and efﬁcacy of antidepressants in particular, selective serotonin
reuptake inhibitors (SSRIs), for treatment of adolescent depression. Many clinical trials supported by the pharmaceutical industry suggest
the potential for adverse events in the use of
SSRIs, including increased suicidal ideation and
suicide attempts (Harris, 2004a, b). Unfortunately, these trials were often kept from public
view. This has led to increased pressure to make
all clinical trials involving drugs available for
public inspection. In addition, an FDA panel has
determined that these trials support the conclusion that SSRIs may carry an increased risk for
suicidal ideation or behavior for a small proportion of users (perhaps 2 or 3%) and as a result
labels warning of these effects will now be placed
on all antidepressants (FDA, 2004).
A recent trial with adolescents suffering from
major depression (Glass, 2004; March et al.,
2004) indicated that treatment with a particular
SSRI (Prozac) was less likely to produce adverse
events when combined with CBT. Based on this
evidence as well as considerable research suggesting the effectiveness of CBT as well as IPT
with adolescents (reviewed by the depressionbipolar commission), it may be that combined
treatment is the best approach for adolescents
who present with depression and suicidal
thoughts or behaviors. Since many physicians
and mental health providers may not be trained
to deliver CBT or IPT, there is a clear need to increase the number of practitioners who can provide these alternatives. Use of CBT or IPT may be
the preferred alternative for less severe cases,
since it has proven efﬁcacy and does not run the
risk of increased suicidal behavior.
It is encouraging to note the appearance of
several initiatives designed to increase public ac-
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cess to the results of clinical trials evaluating the
effects of therapeutic interventions. Eleven major medical journals have established a policy requiring the registration of such trials at inception before ﬁndings can be considered for
publication (DeAngelis, Drazen, Frizelle, Haug,
Hoey, Horton, et al., 2004). The American Medical Association has endorsed the concept of a
federally mandated registry of clinical trials
(Council of Scientiﬁc Affairs, 2004). Legislation
mandating registration has been introduced in
both the House and Senate (Fair Access to Clinical Trials Act, 2004). All of these efforts encourage greater use of the existing federallysponsored but voluntary repository of clinical
trails, www.clinicaltrials.gov. We look forward to
the eventual open access to all results regarding
the efﬁcacy of medication and other therapies as
well as reports of adverse reactions experienced
following regulatory approval.
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TREATMENT FOR SUBSTANCE ABUSE
Treatment for drug dependence in adolescents
raises a host of issues because some drugs of dependence (e.g., marijuana) are banned by law
and their use is treated as criminal behavior. This
is unfortunate because dependence on most
drugs can be successfully treated if the family is
involved in the therapy (see Chapter 18). Furthermore, drug dependence is often comorbid
with other mental conditions that would beneﬁt
from treatment as a medical problem rather than
as criminal behavior. Because the treatment system for substance abuse is not integrated with
treatment for mental conditions (see below),
those with both suffer needlessly.

EARLY DETECTION AND TREATMENT AS A
PREVENTION STRATEGY
It is now clear that most cases of adult mental
disorders make their ﬁrst appearance prior to or
during adolescence (Kim-Cohen, et al., 2003;
Roza, Hofstra, van der Ende, & Verhulst, 2003).
This reality makes the early detection and treatment of mental disorders even more critical (see
also The President’s New Freedom Commission
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on Mental Health, 2003). The earlier a condition
is identiﬁed and treatment begun, the less serious the course of illness and the lower the likelihood that it will disrupt healthy adolescent development. This is particularly important for
substance dependence, including smoking, because there is evidence of nervous system plasticity during adolescence. A drug habit learned
early produces brain changes that may be lifelong. If early detection and treatment of mental
disorders were the norm, the possibility of reducing subsequent disorder would be increased.
Furthermore, given the high rates of mental disorders as precursors to suicide, their early treatment would boost our chances of preventing this
fatal outcome in youth.
Because it is clear that early detection and referral for treatment should be a high national
priority, it is disappointing to learn from research conducted as part of the commissions
(Chapters 30 and 31) that the primary care system and schools are inadequately prepared to
meet this challenge. Primary care physicians are
not trained to detect mental disorders or substance abuse problems, and most do not employ
screening programs to identify youth at risk for
these conditions. A similar situation exists in the
schools where mental health professionals do
not have the resources to identify youth at risk
for problems. As a result, schools do not intervene until illnesses progress and come to the attention of staff. Unfortunately, the most common disorders in adolescence (depression,
anxiety, and substance abuse) are not as easily
recognized as conduct disorder and attentiondeﬁcit hyperactivity disorder (ADHD), conditions that make their ﬁrst appearance in the
elementary years. Waiting until adolescent conditions seriously interfere with school performance forestalls treatment and reduces the odds
of successful recovery.
Treatment systems also are poorly designed
for delivering care to adolescents. The most glaring example of this, treatment for substance
abuse, is a case study of inadequate response to
a large but potentially manageable problem
(Chapter 29). The long-standing dichotomy between treatment for drug dependence and other
mental conditions creates a barrier that prevents
comprehensive treatment. Since substance abuse
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and mental conditions often co-occur, they
should be treated within the same service system. Furthermore, substance dependence treatment programs often employ ineffective interventions despite the existence of evidence-based
therapies (involving the family) that can produce greater treatment adherence and success.
The integration of treatment services (mental
health, addiction treatment, behavioral health)
across different practitioners in different settings
(primary care, specialty care, schools, juvenile
justice) requires coordination that is difﬁcult to
achieve under the current health care system.
New systems of treatment for mental health that
integrate services are sorely needed. As noted in
Chapter 28 by Hoagwood, several states, most
notably Hawaii, Michigan, and New York, are attempting to implement new public programs
that include evidence-based treatments and are
coordinating structures to ensure that youth are
effectively served. We await further evaluations
of these programs to see if they can solve the
service fragmentation problems that have
plagued mental health treatment for both youth
and adults.
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UNIVERSAL PREVENTION
Aside from early detection of mental disorders,
there is growing evidence that universal prevention programs in schools and other youth settings can help to increase resilience to stress and
encourage healthy growth and decision making.
The evidence in the case of drugs and alcohol as
well as depression is particularly encouraging
(see Chapters 3, 19, and 26). Suicide prevention
programs are also showing encouraging signs
(see Chapter 24). However, in our recommendations for further research (below), we observe
that much remains to be learned about these
programs.

INSURANCE COVERAGE
No discussion of treatment problems can
ignore the weaknesses in insurance coverage
for mental health. The Mental Health Parity
law that went into effect in 1998 is due for re-

newal in 2004, and several changes have been
proposed in the latest legislation to make coverage of mental health conditions more inclusive. Achievement of full parity is an important
policy goal. As a report by the Congressional
Research Service notes (Redhead, 2003), “Requiring parity for mental health beneﬁts establishes a uniform ‘ﬂoor’ of mental health coverage across all plans.” This has the desirable
effect of reducing wasteful competition among
health-insurers to attract the least risky policyholders. In addition, experience in the implementation of full parity in federal health insurance programs indicates that the short-term
increases in costs are small (about 1.6% in feefor-service plans and less than 1% in managed
care) (Redhead, 2003). Hence, short-term cost
does not appear to be a barrier to the implementation of full parity for mental health
services, and the long-term cost savings and
beneﬁts to consumers should make parity costeffective.
Despite the importance of parity legislation,
this policy effort also has serious limitations. At
least 15% of Americans have no health insurance
coverage whatsoever (Mills & Bhandari, 2003).
This means that nearly 12% of youth under the
age of 18 and 30% of young people between the
ages of 18 and 24 without coverage will not be
helped by parity. In addition, parity legislation
affects only those whose insurance already includes coverage for mental health, and it does
not cover treatment for substance dependence
(Redhead, 2003). Hence, even if the current parity legislation were enacted, it would not solve
the problems inherent in the current system of
treatment for mental health.
A potentially favorable development in the
search for solutions to inadequate mental health
coverage is the prospect that managed care programs, which now cover more than half of youth
(Glied & Neuﬁeld, 2001), will evolve to adequately ensure treatment for mental conditions.
One approach adopted by managed care involves the use of specialized services or “carveouts” for behavioral treatment. Through this approach, costs for mental health services can be
contained while patients are directed to appropriate care by specialists (Conti, Frank, & McGuire, 2004). In principle, the short-term costs of
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mental health services can be effectively managed. Nevertheless, it remains to be seen if managed care can adequately accommodate youth
who require more long-term treatment to either
complete a full course of psychotherapy or maintain treatment and avoid relapse (Glied & Neuﬁeld, 2001; Kelleher, Scholle, Feldman, & Nace,
1999).
Another challenge for managed care and
other insurance plans is to identify those practitioners who can treat adolescent mental problems effectively. Surveys of both primary care
providers and school mental health professionals indicate widespread dissatisfaction with the
quality of care available in local communities for
adolescents having the disorders studied by our
commissions. The effectiveness of early detection and treatment of adolescent mental disorders is thus limited. There is an urgent need to
increase the pool of providers able to deliver
evidence-based treatments to youth so that
availability of such services is no longer a barrier
to referral by schools and primary care providers.
School mental health professionals and nurses as
well as primary care providers need links with
quality treatment centers to which they can refer
adolescents in need.
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STIGMA OF MENTAL DISORDER
Research conducted by Penn and colleagues
(Chapter 27) indicates that young people hold
stigmatizing beliefs about mental disorders and
that these beliefs can inﬂuence their treatment
decisions. If youth feel that they will be stigmatized for seeking treatment, they will resist coming forward when experiencing symptoms. One
approach to reducing this dysfunctional response is to increase public awareness of the efﬁcacy of treatment for mental disorders. If adolescents (and their parents) recognize the
potential effectiveness of early detection and
treatment, they may be more inclined to seek
help from providers who are seen as effective in
treating their problems. Hence, through awareness of treatment efﬁcacy, the effects of stigmatizing beliefs may be moderated and youth encouraged to seek help from providers.
Educating the public about the effectiveness
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of treatment and the reality that persons with
mental disorders can lead productive lives is a
strategy that deserves the support of the advocacy community and government agencies. The
current mental health media campaign sponsored by the Substance Abuse and Mental Health
Services Administration (SAMHSA) as part of its
Elimination of Barriers Initiative (2004) is one
example of such an effort.

RESEARCH NEEDS
Estimates of the economic costs of mental and
substance abuse disorders in the United States
are in excess of $200 billion per year (Redhead,
2003; U.S. Department of Health and Human
Services, 1999). By increasing our ability to prevent and treat these disorders in young people,
we have the potential to reduce this burden signiﬁcantly while substantially increasing the nation’s welfare. We see two kinds of research opportunities for improving our ability to prevent
and treat mental disorders in youth. At the procedural level, there are many unanswered questions about appropriate protocols and systems
for treatment. Although we have treatments that
work, we still don’t know enough about the best
ways to combine treatments for maximum effect
or the optimal ways to withdraw treatments
without leading to relapse. We also need more
research on the best ways to treat persons with
comorbid conditions, especially addiction.
Moreover, we have no direct evidence of efﬁcacy
for the treatment of some adolescent anxiety
and eating disorders, and schizophrenia still remains a treatment challenge.
We also know that universal prevention of
some conditions is possible (Chapters 3 and 19)
and that the healthy development of youth can
be enhanced considerably using positive youth
development strategies (see Chapter 26). Nevertheless, much remains to be learned about integrating effective programs into schools and communities in a cost-effective way. The promise of
positive psychology is still untested and requires
more research.
We also lack knowledge of the best ways to
conduct screening of youth in schools and primary care settings so that care is delivered to
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them. Many young people identiﬁed in screening programs as needing services fail to seek
them. There are several promising models (discussed by the suicide commission) but not
enough evidence about their efﬁcacy or ability
to be taken to scale to permit widespread adoption.
A second major opportunity for research is to
increase our understanding of the multiple pathways to both healthy and unhealthy development. Because we know little about the ways in
which disorders unfold, it is difﬁcult to design
appropriate interventions at the earliest signs of
disorder. One shortcoming in previous research
is that investigators inevitably focused on the
one or two disorders in which they had expertise. Unfortunately, the many disorders that appear in adolescence do not accommodate this
neat developmental pattern. Disorders that ﬁrst
appear in childhood may later develop into
other forms and some may develop together
(Kim-Cohen et al., 2003). Early emergence of
some conditions may be left behind never to appear again. These complex patterns of comorbidity and development have been a frequent ﬁnding in the commission reports. The challenge for
future research is to examine a broad range of
potential psychopathology as well as sources of
resilience in one design in which different developmental pathways can be studied at the
same time.
Fortunately, research strategies to better understand the causal inﬂuences on varied developmental trajectories are available (Curtis &
Cicchetti, 2003; Masten, 2004). Longitudinal
studies of representative populations can help to
identify the paths and inﬂuences that affect the
emergence of a disorder (e.g., Caspi et al., 2002;
Kim-Cohen et al., 2003). Studies of twins embedded in such studies make it possible to identify
genetic and interacting environmental factors
that alter trajectories toward either resilience or
disability (Rutter et al., 1997; Waldman, 2003).
Once potential causal inﬂuences have been isolated, their effects can be studied in more focused longitudinal designs that select high-risk
youth for prospective investigation. Clinical trials that follow young people over time can test
the effects of theoretically derived interventions,

thereby adding further knowledge of causally efﬁcacious treatments (Masten, 2004).
A research project designed to follow a large
representative sample of children and twins that
will enable the study of different developmental
pathways throughout the early years and into
adulthood is prohibitively expensive, even for
the National Institute of Mental Health. Funding
for such an endeavor will require the collaboration of a multitude of investigators with different
areas of expertise, and it will necessitate the cooperation of both federal and private funding
sources. It is clear, however, that such a study
would greatly advance our understanding of the
emergence of mental disorder and resilience in
youth and allow further tests of intervention
strategies that could reduce the burden of mental
disorders in adolescence and adulthood.

THE FUTURE
With recent advances in neuroscience, it is now
clear that adolescence is a period of dramatic
change in brain structure and function (Giedd,
2004; Spear, 2000). The brain is an eminently
plastic organ that develops both in accord with
genetic rules and in response to its environment
(Huttenlocher, 2002). Adolescence is particularly
critical because it is the period during which signiﬁcant “pruning” of synaptic connections occurs. The connections that remain may allow experience to mold a more adaptive brain, but they
also open the door to illness and dysfunctional
behavior. We remain far from understanding the
mechanisms that produce these varied outcomes, but the potential for therapeutic interventions to correct dysfunctional neurodevelopment and to enhance resilience is a clear
possibility. As we learn more about these effects,
possibilities for dramatic breakthroughs in our
ability to prevent and alter dysfunctional trajectories will present themselves (Kandel, 1998).
Our new understanding of brain development
is rendering the old debates between nature and
nurture or biology vs. behavior increasingly irrelevant (Kandel, 1998). Gene expression is responsive to environments and hormonal
changes. As Kandel (1998) put it, “nurture will
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become nature,” and our ability to inﬂuence
such developments in positive ways will greatly
enlarge the scope of preventive interventions.
Increasing evidence of brain plasticity during the
adolescent years suggests that both biologically
and socially based interventions can inﬂuence
development and alter dysfunctional developmental paths. The battleground between oppos-
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ing biological and environmental viewpoints
may be merging into a synthesis that recognizes
the value and promise of both sides of these debates. These new frontiers in the study of psychopathology make this a most exciting time for
advancing our knowledge and ultimately for preventing the onset and development of mental
disorders at the earliest signs of presentation.
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